Keliomics, Inc. — Form D/A
Keliomics, Inc. of PORTLAND, OR, a company, filed a Form D amendment with the SEC on 2023-11-30. The offering totals $7.0M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-30
- Form: D/A
- Accession: 0001949231-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $2.3M
- Remaining: $4.7M
- Investors: 17
- Date of first sale: 2022-09-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-461343
Issuer
- Name: Keliomics, Inc.
- CIK: 0001949231
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4640 S. MACADAM AVENUE, PORTLAND, OR, 97239
- Phone: (617) 935-2625
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jason Bourgeois | Director | Portland, OR |
| Frank Lau | Director | Portland, OR |
| Jason Bourgeois | Executive Officer | Portland, OR |
| Frank Lau | Executive Officer | Portland, OR |
Other filings by this issuer (1)
More